STUDENT RIGHTS AND RESPONSIBILITIES:
INTERROGATIONS AND SEARCHES
FNF-R (LOCAL)

STUDENTS IN EXTERNAL PROGRAMS	Students who participate in certain instructional programs conducted in facilities not owned or operated by the District may, according to the rules or regulations of the facility, be required to submit to drug testing as a condition of participation in the program. Students who do not consent to such testing may pursue other learning opportunities.
DISTRICT CONTACT PERSON	The Associate Superintendent for Curriculum Development is the District contact person for the drug-testing program and for the company in charge of performing the testing. The Assistant Superintendent for Curriculum Development or designee will coordinate the drug-testing program and will answer questions.
IDENTIFICATION OF STUDENTS	The testing group includes students who have been offered an opportunity to participate in an instructional program conducted by a non-District facility that requires a drug test prior to participation. Students shall be notified of this requirement upon enrollment in the program. Students who choose to participate in such external programs shall be tested, at PISD expense and at pre-announced dates, prior to the beginning of each academic semester in which the student will participate in the program.
CONSENT TO DRUG AND ALCOHOL TESTING   REFUSAL TO CONSENT   PRIVACY IN DRUG OR ALCOHOL SCREENING	The District shall test students who seek to participate in the programs described above only if the student and parent (if the student is under the age of 18) agree, in writing, to submit to the test.    A student who refuses to consent to drug testing shall be denied participation in the voluntary instructional program for which such testing is required. Such students shall pursue other learning activities. 1.    Students will be afforded privacy in providing urine samples such that they may not be viewed while providing the sample unless the District or its representative has reason to believe the student will attempt to alter or substitute the sample. Such reasons are limited to those set forth in 49 CFR 40.25, including: When the student has presented a urine specimen that falls outside the normal temperature range (32 - 38 C / 90 - 100 F) and the student declines to provide a measurement of oral body temperature or the student’s oral body temperature varies by more than 1 C / 1.8 F from the temperature of the specimen; A urine specimen has an unusual color, presence of foreign objects, or other signs of tampering (e.g., an unusual odor); or Collection site personnel observe conduct clearly and unequivocally indicating an attempt to substitute or altercate the sample. Students shall not bring personal items such as briefcases, purses, book bags, or other containers into the testing area. Students shall also be required to remove all personal effects from their pockets prior to entering the collection site. Other appropriate measures, in accordance with applicable federal and state law and regulations, may also be taken to prevent dilution and/or contamination of samples.
PROCESSING OF SAMPLES	Collection of urine samples will be conducted in a controlled laboratory environment using a split sample. Upon receipt of the urine sample from the person being screened, the person supervising the screening will test the temperature of the urine and initiate the processing of the sample. The sample will be sealed, and the person supervising the sample will sign the sealed sample. The sample will be labeled with a control number, the date, and the time the specimen was obtained. The seal will be broken only by the individual performing the analysis. All drug tests will be conducted by a laboratory certified by the Department of Health and Human Services (DHHS), also commonly referred to as a “NIDA-certified” laboratory. The laboratory will be instructed to initially perform an immunoassay test known as an “EMIT” screen. If the EMIT screen is positive, the results will be confirmed by a second test utilizing gas chromatography/mass spectrometry (GC/MS). The laboratory shall be instructed to perform only tests relating to the presence of the illegal drugs listed below, and under no circumstances shall the laboratory be permitted to perform additional tests.
DRUGS TO BE SCREENED FOR	When drug screening is required, a urinalysis and/or EBT will be given to detect the presence of the drugs listed below. Confirmatory tests will be performed only in the event the initial screen is positive. A positive result means that a specimen has been found to contain the drugs and/or their metabolites in excess of the levels set forth below and has been reviewed and verified by the medical review officer. These screening levels are subject to change by the District as advances in technology or other considerations warrant identification of those substances at other concentrations.
	Drug Class Initial Screen Confirmatory Screen Marijuana 50 ng / ml 15 ng / ml Cocaine 300 ng / ml 150 ng / ml Opium 300 ng / ml 300 ng / ml Phencyclidine 25 ng / ml 25 ng / ml Amphetamines 1,000 ng / ml 500 ng / ml
REPORTING OF RESULTS	The laboratory will report the results of the test to a medical review officer (MRO). A MRO is a physician, not associated with the laboratory, who has knowledge of substance abuse disorders and has appropriate training to interpret and evaluate a confirmed positive test along with the individual's medical history and related biomedical information.   All information from a student’s drug test is confidential, and only those District officials with a specific need to know may be informed of screening results by the MRO. Disclosure of test results to any other person, agency, or organization is prohibited unless written authorization is obtained from the student tested or as provided by applicable state and federal laws and regulations. All records relating to the taking of a drug screen shall be deemed confidential, unless written authorization has been obtained from the person, except in accordance with applicable laws and regulations or if the records become the subject of an administrative or judicial proceeding. Records of drug tests and results will be maintained by the Associate Superintendent for Curriculum Development, and access to the records shall be strictly limited. Retention and storage of samples and records shall be conducted in accordance with DHHS guidelines for drug testing programs.
CONSEQUENCES OF A CONFIRMED POSITIVE TEST RESULT	A student who has a positive result after an initial drug screening by the EMIT and a confirmatory test using the GC/MC test which is then verified by an MRO, shall not be eligible for participation in voluntary learning opportunities available through external programs in facilities not owned or operated by the District that require testing as a condition of participation.
USE OF PRESCRIPTION DRUGS	Students should be reminded that the taking of another person’s prescribed medication is not an acceptable reason for having a positive test; this is an illegal use of controlled substances.